“[...] these inexpensive, widely available tests with rapid turnaround times and relatively short half-lives (CEA, CA-125, and CA19-9) are perfectly situated to ...

Demographic factors on the incidence of KRAS mutation in colorectal cancers. Background: Serum tumour markers have an established role in the monitoring of systemic treatment for trophoblastic, ...

“To our knowledge, there are no studies evaluating the prognostic importance of CEA and Ca 19-9 in patients with DA [duodenal adenocarcinoma].” Duodenal adenocarcinoma (DA) is a rare malignancy ...

A new research paper was published in Oncotarget's Volume 15 on June 13, 2024, entitled, "Assessment of serum tumor markers CEA, CA-125, and CA19-9 as adjuncts in non-small cell lung cancer management ...

Medullary thyroid cancer (MTC) is a rare a neuroendocrine tumor that arises from the parafollicular C cells of the thyroid, which are neural crest derivatives and produce calcitonin and ...

Phase II study of capecitabine (C) in combination with docetaxel (D) as neoadjuvant treatment in patients with locally advanced breast cancer (IIIA and IIIB stage) No significant financial ...

Importantly, stomach cancer is also being diagnosed in an increasing number of younger people -- that is, those younger than ...

Researchers have identified a blood protein that can be used as a marker of gastric and other cancers and is more accurate than existing diagnostic biomarkers, even in the early stages of the disease.